Triamcinolone crystal size

Ophthalmology

Volumn 117, Issue 8, 2010, Pages

  Kleinman, Mark E ^a   Westhouse, Scott J ^a   Ambati, Jayakrishna ^a   Pearson, P Andrew ^a   Halperin, Lawrence S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; TRIAMCINOLONE ACETONIDE; TRIESENCE; UNCLASSIFIED DRUG;

CLINICAL ARTICLE; CONTROLLED STUDY; CRYSTAL; DIABETIC MACULAR EDEMA; DRUG EFFICACY; DRUG MANUFACTURE; DRUG SAFETY; DRUG STABILITY; HUMAN; INTRAOCULAR PRESSURE; LETTER; PARTICLE SIZE; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA CYSTOID EDEMA; SUBRETINAL NEOVASCULARIZATION; TRABECULAR MESHWORK; VEIN OCCLUSION;

EID: 77955460854     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.01.052     Document Type: Letter

References (5)

1. J. Jonisch, J.C. Lai, and V.A. Deramo, et al. Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide Br J Ophthalmol 92 2008 1051 1054
2. H. Kim, K.G. Csaky, and L. Gravlin, et al. Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration Retina 26 2006 523 530
3. P. Szurman, R. Kaczmarek, and G.B. Jaissle, et al. Influence of different purification techniques on triamcinolone yield and particle size spectrum Graefes Arch Clin Exp Ophthalmol 245 2007 689 696
4. J. Garcia-Arumi, A. Boixadera, and J. Giralt, et al. Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use Br J Ophthalmol 89 2005 1112 1114
5. A.A. Moshfeghi, A.K. Nugent, and H. Nomoto, et al. Triamcinolone acetonide preparations: impact of crystal size on in vitro behavior Retina 29 2009 689 698